SM
NYMX

Sciencast Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Sciencast Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,568
Closed -$23K – 545
2020
Q1 		$23K Buy
+10,568
New +$29.7K 0.01% 283

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Sciencast Management's NYMX Position: Q2 2020 in Review

Sciencast Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2020, closing a stake of 10,568 shares — an estimated $23K sold.

Sciencast Management first reported a position in NYMX in Q1 2020 and held it in 1 quarter. The position peaked at $23K in Q1 2020. 63 funds tracked by Wall St. Rank hold NYMX as of Q2 2020.

  • Sciencast Management reported no remaining Nymox Pharmaceutical Corp position as of Q2 2020 after selling out during the quarter.
  • Sciencast Management sold 10,568 Nymox Pharmaceutical Corp shares in Q2 2020, an estimated $23K.
  • Sciencast Management first reported a position in Nymox Pharmaceutical Corp in Q1 2020 and held it in 1 quarter.
  • Sciencast Management's Nymox Pharmaceutical Corp position peaked at $23K in Q1 2020.
  • 63 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2020.

Based on Sciencast Management's 13F filing for Q2 2020, filed 29 Jul 2020.